Search

Author/Creator Bodelier, Alexander G. L.

1. Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre cohort study. Issue 8 (9th September 2020)

Authors:
Asscher, Vera E. R.; Biemans, Vince B. C.; Pierik, Marieke J.; Dijkstra, Gerard; Löwenberg, Mark; van der Marel, Sander; de Boer, Nanne K. H.; Bodelier, Alexander G. L.; Jansen, Jeroen M.; West, Rachel L.; Haans, Jeoffrey J. L.; van Dop, Willemijn A.; Weersma, Rinse K.; Hoentjen, Frank; Maljaars,...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 52:Issue 8(2020)
Page Start:
1366
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry. Issue 1 (25th October 2022)

Authors:
Straatmijer, Tessa; van Schaik, Fiona D. M.; Bodelier, Alexander G. L.; Visschedijk, Marijn; de Vries, Annemarie C.; Ponsioen, Cyriel Y.; Pierik, Marieke; van Bodegraven, Ad A.; West, Rachel L.; de Boer, Nanne K. H.; Srivastava, Nidhi; Romkens, Tessa E. H.; Hoekstra, Jildou; Oldenburg, Bas; Dijks...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 57:Issue 1(2023)
Page Start:
117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry. Issue 9 (1st April 2020)

Authors:
Biemans, Vince B. C.; Sleutjes, Jasmijn A. M.; de Vries, Annemarie C.; Bodelier, Alexander G. L.; Dijkstra, Gerard; Oldenburg, Bas; Löwenberg, Mark; van Bodegraven, Adriaan A.; van der Meulen‐de Jong, Andrea E.; de Boer, Nanne K. H.; Srivastava, Nidhi; West, Rachel L.; Römkens, Tessa E. H.; Horju...
Other Names:
Fidder H. H. investigator.; Ponsioen C. Y. investigator.; Duijvestein M. investigator.; Romberg‐Camps M. J. L. investigator.; Maljaars P. W. J. investigator.; Bouma G. investigator.; van der Marel S. investigator.; de Jong D. J. investigator.; Haans J. J. L. investigator.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 51:Issue 9(2020)
Page Start:
880
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti‐TNF treatment. Issue 1 (22nd May 2020)

Authors:
Biemans, Vince B. C.; van der Woude, C. Janneke; Dijkstra, Gerard; van der Meulen‐de Jong, Andrea E.; Löwenberg, Mark; de Boer, Nanne K.; Oldenburg, Bas; Srivastava, Nidhi; Jansen, Jeroen M.; Bodelier, Alexander G. L.; West, Rachel L.; de Vries, Annemarie C.; Haans, Jeoffrey J. L.; de Jong, Dirk;...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 52:Issue 1(2020)
Page Start:
123
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach. Issue 8 (August 2015)

Authors:
Bodelier, Alexander G. L.; Smolinska, Agnieszka; Baranska, Agnieszka; Dallinga, Jan W.; Mujagic, Zlatan; Vanhees, Kimberly; van den Heuvel, Tim; Masclee, Ad A. M.; Jonkers, Daisy; Pierik, Marie J.; van Schooten, Frederik J.
Journal:
Inflammatory bowel diseases
Issue:
Volume 21:Issue 8(2015:Aug.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗